Biogen (BIIB) Tops Q3 EPS by 61c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $216.12 +3.04%
EPS Growth %: -41.5%
Financial Fact:
Amortization of acquired intangible assets: 99.7M
Today's EPS Names:
CRMT, More
EPS Growth %: -41.5%
Financial Fact:
Amortization of acquired intangible assets: 99.7M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $6.31, $0.61 better than the analyst estimate of $5.70. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $3.03 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
- Rivian raises 2026 delivery outlook after Q2 results top guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
